Combination of Rivaroxaban and Amiodarone Increases Bleeding in Patients With Atrial Fibrillation

CONCLUSION AND RELEVANCE: The combination of rivaroxaban and amiodarone increased the risk of bleeding in patients with atrial fibrillation, especially clinically relevant nonmajor and minor bleeding. Physicians prescribing rivaroxaban and amiodarone together should be concerned about an increase in the risk of nonmajor bleeding.PMID:37960871 | DOI:10.1177/10600280231211306
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: Source Type: research